anti-influenza intravenous hyperimmune immunoglobulin
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for anti-influenza intravenous hyperimmune immunoglobulin, covering 2019-11-14 to 2019-11-14. Get the full timeline:
Most recent: Clinical Trial Update: Evaluating the Safety and Efficacy of Anti-Influenza Intravenous Hyperimmune Immunoglobulin (IVIG) in Adults Hospitalized With Influenza [Phase 3]